Using a quick CT scan to check for left atrial clots before cardioversion in the Emergency Department
Official title: Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Department (LA CLOTTED)
Run by Ottawa Heart Institute Research Corporation · NCT07002450 · Data updated 2026-11-12
This will test whether a rapid cardiac CT in the ED to look for left atrial clots lets people with symptomatic atrial fibrillation or flutter have safe same‑day cardioversion instead of being admitted or delayed.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 190 (estimated) |
| Sponsor | Ottawa Heart Institute Research Corporation Academic / other |
| Drugs / interventions | radiation |
| Locations | 3 sites (Hershey, Pennsylvania and 2 other locations) |
| Status | Recruiting |
| Started | June 15, 2025 |
| Main results expected | June 15, 2028 |
| Study ends | June 15, 2028 |
| Registry record updated | June 9, 2026 |
| Trial ID | NCT07002450 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with symptomatic atrial fibrillation or atrial flutter who require left atrial imaging before cardioversion and who are hemodynamically stable and able to receive iodinated contrast and hold their breath for the scan are ideal candidates.
✕Probably not a fit
Patients who need emergency cardioversion for instability or who cannot undergo CCT (severe renal impairment, contrast allergy, pregnancy, or inability to breath‑hold) are unlikely to benefit from this CT‑facilitated approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized multicenter trial compares cardiac computed tomography angiography (CCT)–facilitated cardioversion in the emergency department to current standard care for patients with symptomatic atrial fibrillation or flutter who need left atrial imaging before cardioversion. Patients randomized to the CCT arm will have a CT to rule out thrombus and, if no clot is seen, may undergo immediate chemical or electrical cardioversion in the ED; the control arm follows local standard practice (which may include TEE, admission, or outpatient anticoagulation). The study will measure hospital admission rates, repeat ED presentations, and patient quality of life with follow-up at 30 days. CCT is more widely available than TEE and has shown high sensitivity and specificity for detecting left atrial thrombus in diagnostic studies, so this trial tests the pathway impact of using CCT in real-world ED care.
Why it matters
Potential benefit: If successful, eligible patients could be cardioverted safely in the ED after a rapid CT, reducing hospital admissions, repeat visits, and time spent in symptomatic arrhythmia.
How similar studies have gone: Diagnostic studies show CCT has high sensitivity and specificity compared with TEE for detecting atrial thrombus, but randomized trials of ED CCT‑guided cardioversion are limited, making this approach relatively novel in trial form.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years old; and 2. Primary symptomatic AF without a reversible underlying cause (e.g. sepsis, pneumonia, pulmonary embolism, hyperthyroidism) 3. LA imaging required before cardioversion according to local clinical practice guidelines Exclusion Criteria: 1. Patients with an indication for emergency cardioversion (e.g. hemodynamic instability (systolic blood pressure\<90mmHg or signs of shock), cardiac ischemia (ongoing severe chest pain or marked ST depression on ECG \>2mm), or pulmonary edema (significant dyspnea, crackles, or hypoxia)); or 2. Contraindication to CCT (renal insufficiency (eGFR\< 45ml/min/1.73m2), allergy to intravenous contrast agents, pregnancy (contraindications to radiation exposure), or inability to perform 20-second breath-hold)
Where it's running
-
Penn State Health Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States Recruiting -
The Ottawa Hospital Civic Campus
Ottawa, Ontario, Canada Recruiting -
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Benjamin Chow, MD PhD FRCPC FACC FESC FA — Ottawa Heart Institute Research Corporation
- Study coordinator: Farrah Ahmed
- Email: fahmed@ottawaheart.ca
- Phone: 613-696-7000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Early rhythm control treatment for subclinical atrial fibrillation
This study tests whether starting rhythm-control treatments early can reduce abnormal heart rhythm episodes in people whose subclinical atrial fibrillation was found by implantable heart devices.
-
ICE-guided cavotricuspid isthmus ablation with a circular pulsed-field catheter
This will see if a circular-shaped pulsed field ablation catheter, guided by intracardiac echocardiography, can safely and effectively achieve acute cavotricuspid isthmus ablation in adults with atrial fibrillation.
-
Tracking outcomes after heart rhythm procedures in Düsseldorf.
This registry collects information to see how safe and effective routine electrophysiology procedures (like catheter ablation and cardioversion) are for people treated for AF, atrial flutter, supraventricular tachycardias, or VT at University Hospital Düsseldorf.
-
Pulsed field ablation registry for atrial arrhythmias in Poland.
This project will collect information to see how well pulsed field ablation works and how safe it is for people in Poland having ablation for atrial fibrillation, atrial flutter, or atrial tachycardia.
-
Comparing LAA closure and anticoagulation for atrial fibrillation patients after brain bleeding
This study is testing whether closing a part of the heart or using blood thinners is better for preventing strokes in patients with atrial fibrillation who have had a brain bleed.
-
Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation
This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.